Ocugen Inc (OCGN)
$0.63
0.00 (0.00%)
OCGN Stock Quote Delayed 15 Minutes
Previous Close
$0.63
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
Day's Range
0.63 - 0.63
52-Week Range
0.24 - 8.62
Dividend & Yield
N/A (N/A)
OCGN Stock Predictions, Articles, and Ocugen Inc News
Ocugen Is a Bold Biotech Bet, But the Payoff Could Be Rich
A pipeline of treatments for underserved eye conditions like oGVHD makes OCGN stock worth considering as part of your biotech holdings.
Ocugen Stock Might be up 34% in 2020 but There are Other Eye Care Plays
Except for a couple of specific investors, Ocugen stock is not one for average people. Instead, look at Bausch Health Companies, which has a very rocky backstory but has managed to turn the corner.
Ocugen Stock Is Not for the Faint of Heart
Ocugen stock has an intriguing bull case based on its pipeline. But the nano-cap biotech is as risky as any stock in the space.
Avoid Ocugen Stock as Science and the Markets Clash
OCGN stock makes an attractive speculative case because of the underlying company’s potential to address rare eye diseases. Still, this is an opportunity that only risk-takers with “dumb money” should engage.
For Penny Investors, Ocugen Stock Makes a Good Speculative Play
With two orphan drug designations and a promising partnership, Ocugen stock makes a good play for speculative investors.
With No Revenue or Approved Treatments, Ocugen Stock Is a Clear Sell
How Ocugen stock came to be makes no sense. Neither does the idea that investors will continue to pour money into this cesspool.
Ocugen Stock Is Nothing More than a Risky Trade on Even-riskier Biotech
Ocugen gave rise to OCGN stock through a reverse merger with Histogenics. But despite this confusing deal, it really didn't do much for either company in the end.
Ocugen News: OCGN Stock Soars 40% on Stock Buyback Plan
Ocugen (OCGN) news for Wednesday about a massive stock buyback plan for $2 million worth of shares has OCGN stock on the move.
